Application no. and date | 10768347.6 (espacenet) (Federated) (European Patent Register), 20101013 | Patent/reg. no. and date | DK/EP 2488512, 20131127 | Publication date | 20120822 | Priority no. and date | US 251477 P, 20091014 | EP pub. no. and date |
EP 2488512 20120822 | Effective date | | Applicant/owner | Bristol-Myers Squibb Company, Route 206 & Province Line Road
Princeton, NJ 08543-4000, US | Applicant ref. no. | 13202-4 | Inventor | LUO, Guanglin, c/o Bristol-Myers Squibb Company 5 Research Parkway Wallingford
Connecticut 06492, US, DUBOWCHIK, Gene M., c/o Bristol-Myers Squibb Company 5 Research Parkway Wallingford
Connecticut 06492, US, MACOR, John E., c/o Bristol-Myers Squibb Company 5 Research Parkway Wallingford
Connecticut 06492, US | Representative | Marks & Clerk LLP, 44 rue de la Vallée
BP 1775
L-1017 Luxembourg, LU | Opponent | | IPC Class | A61K 31/4704 (2006.01) , A61K 31/473 (2006.01) , A61K 31/4745 (2006.01) , A61K 31/4747 (2006.01) , A61K 31/517 (2006.01) , A61K 31/519 (2006.01) , A61K 31/551 (2006.01) , A61P 11/06 (2006.01) , A61P 25/06 (2006.01) , C07D 401/12 (2006.01) , C07D 471/04 (2006.01) , C07D 471/10 (2006.01) , C07D 471/20 (2006.01) | Title | CGRP-RECEPTORANTAGONISTER | Int. application no. | US2010052433 | Int. publication no. | WO2011046997 | Related patent (certificate) | CA 2022 00036 | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|